-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Maintains Neutral on Edwards Lifesciences, Lowers Price Target to $87

Benzinga·12/16/2025 11:30:46
語音播報
Baird analyst David Rescott maintains Edwards Lifesciences (NYSE:EW) with a Neutral and lowers the price target from $88 to $87.